drugset / Trial / NCT04779606

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

NCT04779606

Phase 1/2 Completed 105 enrolled Sintetica SA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study evaluate the efficacy, safety and local tolerability of Chloroprocaine 3% ophthalmic gel as compared to matching placebo in healthy subjects.

Timeline

Start
2020-06-16
Primary completion
2020-10-13
Completion
2020-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 30 mg/ml Other

Indications

No indication recorded.